HIF hydroxylation and the mammalian oxygen-sensing pathway
Open accessThe DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Abstract
Hypoxia refers to below-normal levels of oxygen in air, blood, or tissue.Tissue hypoxia leads to cellular dysfunction and ultimately can lead to cell death.Causes of tissue hypoxia include (a) decreased blood oxygenation (such as occurs in certain pulmonary disorders), (b) altered oxygen release from hemoglobin (associated with some hemoglobinopathies), and (c) impaired blood delivery leading to localized anemia (i.e., ischemia) as a result of low cardiac output or vascular obstruction.In order to adapt to hypoxia, mammals use a number of physiological responses.These include (a) increased production of erythropoietin (EPO), which augments the production of red blood cells; (b) induction of tyrosine hydroxylase, which facilitates the control of ventilation through the carotid body; and (c) the stimulation of new blood vessels by upregulation of VEGF (1).At the cellular level, hypoxia induces a number of metabolic changes that allow for continued energy generation despite decreased oxygen availability. Hypoxia-inducible factorOne of the most important factors in the cellular response to hypoxia is hypoxia-inducible factor (HIF), which transcriptionally activates genes encoding proteins that mediate adaptive responses to reduced oxygen availability.HIF is a heterodimer consisting of one of three α subunits (HIF1-α, HIF2-α, or HIF3-α) bound to the aryl hydrocarbon receptor nuclear translocator (ARNT), which is also known as HIF1-β.HIF-α is a member of the basic helix-loop-helix (bHLH) superfamily, in which the HLH domain mediates sub-unit dimerization while the basic domain binds to DNA.HIF-α, like some other bHLH family members, contains a Per/Arnt/Sim (PAS) domain that facilitates the heterodimerization of HIF-α with ARNT (2-4).HIF target genes play critical roles in metabolism, angiogenesis, cell proliferation, and cell survival.Examples of HIF target genes include VEGF, glucose transporter 1 (GLUT1), and EPO.HIF binds to the hypoxia-responsive element, which contains the core recognition sequence 5′-TACGTG-3′ (5), in the cis-regulatory regions of hypoxia-inducible genes.Transcriptional activation by HIF is linked to its ability to recruit coactivator proteins such as CREB-binding protein (CBP), p300, steroid receptor coactivator-1, and translation initiation factor 2 (6-8).Whereas changes in oxygen levels do not affect ARNT protein levels, hypoxia markedly increases the abundance of the HIF-α subunits (9-11).This increase is due primarily to protein stabilization.In some settings, hypoxia also leads to increased HIF1-α mRNA accumulation (12,13).von Hippel-Lindau disease von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome that affects approximately 1 in 35,000 individuals.The syndrome was first described in 1894 by Collins, who observed two siblings with bilateral retinal angiomas (now also called hemangioblastomas) (14).Later, the disease was mapped to chromosome 3p25 (15), and the VHL gene itself was isolated in 1993 (16).VHL behaves as a classical tumor suppressor gene.Almost all individuals with a clinical diagnosis of VHL disease can be shown to harbor a germline mutation of the VHL gene, with tumor development linked to somatic inactivation or loss of the remaining wild-type allele (17).The cardinal features of VHL disease are blood vessel tumors of the retina and central nervous system.Other tumors associated with VHL disease include clear cell carcinomas of the kidney, pheochromocytoma, endolymphatic sac tumors, pancreatic islet cell tumors, and papillary cystadenomas of the epididymis (in males) or broad ligament (in females) (18).In addition, patients with VHL often develop multiple visceral cysts involving organs such as the pancreas and kidneys (18).Biallelic VHL inactivation also occurs commonly in patients with sporadic hemangioblastoma or renal cell carcinoma,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since pVHL binding to the ODD domain is dependent on PHD activity (Kaelin, 2002;Safran and Kaelin, 2003)”
From Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase (2005) · cites this paper as Safran and Kaelin, 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Self-citationEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Research works printed but not linked: 3
- Collins, E.T. 1894. Intra-ocular growth (two cases, brother and sister, with peculiar new growth, probably retinal, affecting both eyes). Trans. Ophthalmol. Soc. U. K. 14 :141-149.
- Clifford, S.C., Prowse, A.H., Affara, N.A., Buys, C.H., and Maher, E.R. 1998. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer. 22 :200-209. · DOI · Paper page
- Yang, J., Haworth, S., Steinberg, S., Rosenberg, S., and Novotny, W. 2002. A randomized double-blind placebo-controlled trail of bevacizumab (anti-VEGF antibody) demonstrating a prolongation in time to progression in patients with metastatic renal cancer. Proc. Am. Soc. Clin. Oncol. 21 :15 (Abstr.).
Cited by
Items 301–375 of 375
Hormonally Regulated Transcription Factors
Bolander, F. F. (2004) · Elsevier eBooks · doi:10.1016/b978-012111232-5/50013-0 · Cited by 2
Vascular Endothelial Growth Factor: Basic Biology and Clinical Applications
Ferrara, N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-087-8_2 · Cited by 1
Structure Characterization of Low Molecular Weight Target Analytes: Electrospray Ionization
Thevis, M. (2010) · Wiley eBooks · doi:10.1002/9780470626634.ch4 · Cited by 1
Reciprocal Crosstalk Between Angiogenesis and Metabolism
Laurent, G., & Mechta‐Grigoriou, F. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0466-8_10 · Cited by 1
Martorell, L., Rius, J., Crespo, J., Badimón, L., Rodríguez, C., & Martínez‐González, J. (2010) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2009.12.002 · Cited by 1
Huang, S., Raghavaraju, G., & Liu, H. (2010) · Intervirology · doi:10.1159/000317289 · Cited by 1
Posttranscriptional adaptations of the vascular endothelium to hypoxia
Ho, J. J. D., & Marsden, P. A. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000139 · Cited by 1
Ferrara, N. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9148-5_1 · Cited by 3
Binkley, E. M., & Wiley, L. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-04489-3_7 · Cited by 1
Tripmacher, R. (2005) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15260 · Cited by 7
Saria, R. (2014) · theses.fr (ABES) · doi:10.70675/63282e36zb8ffz4e37z875dzfdf5b1d9e02a · Cited by 1
Smith, G. (2015) · Enlighten: Theses (The University of Glasgow)
Hypoxia‐Induced Gene Regulation through Hypoxia Inducible Factor‐1α
Case, A. J., & Domann, F. E. (2009) · Wiley eBooks · doi:10.1002/9783527627585.ch9
Neto, F., & Góes, F. (2011) · Acceda (Universidad de Las Palmas de Gran Canaria) · Cited by 1
Physiological adaptations to chronic hypoxemia in eisenmenger syndrome
Bowater, S. E. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Modeling Blood Vessel Formation in the Mouse
Benezra, R., Rafii, S., & Lyden, D. C. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc016
Non-neuronale Expression und Funktion des sensorischen Kationenkanals TRPA1 in Tumorzellen
Schäfer, E. (2014) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16905
Hypoxic stabilization and proteolytic degradation of erythroid-specific 5-aminolevulinate synthase
Abu‐Farha, M., & Willmore, W. G. (2004) · International Congress Series · doi:10.1016/j.ics.2004.08.073
Uehara, M., Nonaka, M., Hayashi, Y., & Asahina, I. (2008) · Oral Medicine & Pathology · doi:10.3353/omp.12.125
Pathophysiology and Clinical Implications of Vascular Endothelial Growth Factor
Ferrara, N. (2007) · Springer eBooks · doi:10.1007/978-3-540-33177-3_5 · Cited by 1
Vascular endothelial growth factor (VEGF) inhibitorsin cancer therapy: an update
Homsi, J., Kim, L. C., Münster, P. N., Chodkiewicz, C., & DAUD, A. I. (2006) · The Women s Oncology Review · doi:10.1080/14733400600739731
Signaling through NADPH oxidases
Djordjevic, T. (2006) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.8339
Differentiation of the invasive cytotrophoblast lineage in normal pregnancy and in preeclampsia
Winn, V. D., Red‐Horse, K., & Fisher, S. J. (2008) · CRC Press eBooks · doi:10.3109/9780203091500-36
The Biological Role of Factor-Inhibiting Hypoxia- Inducible Factor
Khan, M. N. (2008) · Spiral (Imperial College London) · doi:10.25560/4645
SAPMAZ, F. P., Ünverdi, S., Azak, A., Duranay, M., Fidan, Y., & Yücel, D. (2016) · West Indian Medical Journal · doi:10.7727/wimj.2015.338 · Cited by 1
Molecular mechanisms regulating implantation
Pawar, S. (2014) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Bevacizumab: Current Approach in the Treatment of Hepatocellular Carcinoma
钱, 坤. (2011) · Medical Diagnosis · doi:10.12677/md.2011.11001
Diabetic Bone Marrow & Stem Cell Dysfunction
Piccinin, M. A. (2015) · Scholarship@Western (Western University)
The Diabetic Retina: Anatomy and Pathophysiology
Stewart, M. W. (2017) · Springer eBooks · doi:10.1007/978-981-10-3509-8_2
Systematische Ansätze zur Optimierung der Laufschnelligkeit
Herdener, L. (2014) · mediaTUM (Technical University of Munich)
Investigating the Role of miRNA-34 family in human thyroid cancer
Maroof, H. (2017) · Griffith Research Online · doi:10.25904/1912/1996
Role of intravitreal bevacizumab in the treatment of neovascular glaucoma
Prabhakaran, A. (2010)
Estudos metabolômicos na apneia obstrutiva do sono
Lebkuchen, A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-28032018-113945
Mammalian Heat Shock Protein Hsp105: The Hsp70 Inducer and a Potent Target for Cancer Therapy
Saito, Y., & Nakayama, Y. (2018) · Heat shock proteins · doi:10.1007/978-3-319-89551-2_18
Higgs, D. R., & Wood, W. G. (2005) · Wiley eBooks · doi:10.1002/9780470987056.ch2
Interacción entre las vías HIF, Notch y SUMO y su implicación en la biología de las hMSCs
Calduch, M. C. (2018) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/114769
Meléndez‐Rodríguez, F. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Hoggatt, J., Datari, S. R., & Pelus, L. M. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc045.pub3
Pelus, L. M., Hoggatt, J., Singh, P., & Sampath, J. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc045.pub2
Yang, X. (2009) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2009-09358
Regulation of the amyloid precursor protein (APP) gene promoter by hypoxia
Bielecki, A. A. (2006) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2006-10172
Regulation of erythroid-specific 5-aminolevulinate synthase (ALAS2) by hypoxia
Abu‐Farha, M. (2005) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2005-08341
Folkman, J., & Italiano, J. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3431-5.00002-9
The discovery of how cells sense and adapt to oxygen availability
Tian, Y., Li, S., & Zhao, T. (2019) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2019-0642
Schulz, W. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-16286-2_16
Sakitani, M. (2023) · Open Access Journal of Microbiology & Biotechnology · doi:10.23880/oajmb-16000256 · Cited by 5
Mechanistic insights into copper-induced regression of heart hypertrophy.
Bourcy, K. (2011) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/133
Schulz, W. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-42806-7_16
The Cellular Hypoxic Response upon Giardia Duodenalis Infection
DeMichele, E. (2024) · doi:10.11575/prism/46979 · Cited by 1
Jaśkiewicz, M., Moszyńska, A., Króliczewski, J., Cabaj, A., Bartoszewska, S., Charzyńska, A., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2024) · Figshare · doi:10.6084/m9.figshare.26551648
Jaśkiewicz, M., Moszyńska, A., Króliczewski, J., Cabaj, A., Bartoszewska, S., Charzyńska, A., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2024) · Figshare · doi:10.6084/m9.figshare.26551642
Jaśkiewicz, M., Moszyńska, A., Króliczewski, J., Cabaj, A., Bartoszewska, S., Charzyńska, A., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2024) · Figshare · doi:10.6084/m9.figshare.26551645
Cheng, H. L. (2014) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 1
Jaśkiewicz, M., Moszyńska, A., Króliczewski, J., Cabaj, A., Bartoszewska, S., Charzyńska, A., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2024) · Figshare · doi:10.6084/m9.figshare.26551654
Jaśkiewicz, M., Moszyńska, A., Króliczewski, J., Cabaj, A., Bartoszewska, S., Charzyńska, A., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2024) · Figshare · doi:10.6084/m9.figshare.26551651
Jaśkiewicz, M., Moszyńska, A., Króliczewski, J., Cabaj, A., Bartoszewska, S., Charzyńska, A., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2024) · Figshare · doi:10.6084/m9.figshare.26551639
Cabaj, A. (2024) · RCIN (Digital Repository of the Scientifics Institutes) (Institute of Archaeology and Ethnology of the Polish Academy of Sciences) · Cited by 1
Yan, Q., Jiang, S., Zhang, W., Sun, T., Liu, Z., Yin, X., Zheng, C., Hu, T., Zhang, H., & Xie, Y. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105255
Belmokhtar, K. (2011) · theses.fr (ABES) · doi:10.70675/d4872c56z5bd5z40c9zba80z894bbfbb32fa
Bernardin, A. (2023) · theses.fr (ABES) · doi:10.70675/3c33afd3z6778z4990z9abaza780969fe243
Abdelrahim, A., & Serebrovska, Z. O. (2026) · Problems of ageing and longevity (Ukraine) · doi:10.71012/pro-ageing-2026-1-03
Structural Insights into Metal-Chelating Natural Inhibitors of Factor Inhibiting HIF-1α
Akhsanitaqwim, Y., Nakashima, Y., Ikumi, N., & Morita, H. (2026) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6c00734 · Cited by 1
Fangyu, Y., & Shuangquan, K. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101472
Plant Jumonji-C domain containing 7 proteins catalyze lysine-residue hydroxylation
Wang, Y., Bogie, E., Tumber, A., Zouboulis, K., Salah, E., Benesch, J. L. P., Schofield, C. J., & Brewitz, L. (2026) · Insights in Biochemistry and Molecular Biology · doi:10.1016/j.ibmbio.2026.100004
Oxygen-dependent constraint of glycolysis through the mitochondrial electron transport chain
Guajardo-Grence, A., Fernández-Lamadrid, M., Moschini, G., Algeciras, L. M., Mesa‐Ciller, C., Andreu-Martínez, R., Fernández-Arroyo, L., Muñoz, R. V., Calzada, M. J., Martin-Cofreces, N. B., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed1177
REGULATION OF THE HUMAN XANTHINE OXIDOREDUCTASE GENE
Martelin, E. (2004) · Helda - University of Helsinki Institutional Repository
La homeostasis del hierro y una hormona: la hepcidina.
Barrios, Y., Acosta, E., Espinoza, M., Meléndez, A., & Méndez, D. (2007) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2
Metadata
- Authors
- Safran, M., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kaelin, William G.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-03-15
- Volume
- 111
- Issue
- 6
- Pages
- 779-783
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC153778
- OpenAlex
- W2047816152
- Cited by
- 365
- References
- 77
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 8 · 2023: 18 · 2022: 5 · 2021: 10 · 2020: 10 · 2019: 10 · 2018: 8 · 2017: 11 · 2016: 6 · 2015: 10 · 2014: 16 · 2013: 10 · 2012: 15
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- hypoxia-inducible factor, oxygen sensing, tissue hypoxia, hypoxia-inducible factor-1α, ARNT, bHLH transcription factors, PAS domain, hypoxia response element, transcriptional activation, erythropoietin, vascular endothelial growth factor, glucose transporter 1, angiogenesis
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Asparagine, DNA-Binding Proteins, von Hippel-Lindau Disease, Humans, Hydroxylation, Ligases, Nuclear Proteins, Oxygen, Proline, Repressor Proteins, Transcription Factors, Trans-Activators, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Apoptosis Regulatory Proteins, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.